. Cachexia, main muscular groups atrophy and mild palpebral ptosis, associated to ophtalmoparesis were observed. There was symmetrical paresis of both distal and proximal, mainly on the lower limbs and universal areflexia. The sensitive examination revealed distal tactile, thermal and pinprick hypoesthesia.
The electroneuromyography demonstrated demyelinating sensory and motor polyneuropathy, characterized by conduction slowing and increase latency in motor and sensory nerves and conduction block in 2 motor nerves (Table) .
Biochemical tests revealed no thymidine phosphorylase activity and significant increase of serum thymidine and deoxyuridine 9.6 e 8.6 mmol/L, respectively; normal <0.05 mmol/L 3 . The magnetic resonance imaging (MRI) of the brain showed diffuse leukoencephalopathy affecting both cerebral hemispheres, brain stem and cerebellum.
The muscular biopsy revealed type 2 fibers atrophy and irregular muscle fibers in size and shape. At electronic microscopy, intense mitochondrial proliferation and modest glycogen accumulation were observed 3 . The superficial fibular nerve biopsy revealed demyelinating pattern with thin myelin to the axonal caliber in different remyelinating stages.
The genetic molecular study detected multiple deletions on mitochondrial DNA. No depletions were identified. Homozigotic mutation was found on exon 10 (C4202A) of the ECGF1 gene 3 .
DiSCuSSion
There were described less than 100 cases of MNGIE over the world on the literature 1 . Despite being clinically recognizable and a homogeneous disease, its presentation form may vary and exhibit atypical phenotypes 1 . Because it is a rare and recently described disease, many patients are misdiagnosed as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP) and intestinal inflammatory disease 4 . The peripheral neuropathy presented by the patient fulfills the current clinical, electrophysiological and histopathological criteria for CIDP 5 . In 2004, there were described 5 cases of neuropathy simulating CIDP in patients with MNGIE 4 . Similarities and differences between these two conditions were highlighted. In MNGIE polyneuropathy, proximal weakness is less common than CIDP. Furthermore, there are many other systemic symptoms associated to this disease. Among the studied cases, none of them obtained clinical improvement with immunomodulating therapy 4 . The diagnosis of MNGIE was finally confirmed with biochemical analysis demonstrating absence of thymidine phosphorylase activity and serum raise of thymidine and deoxyuridine, in addition to identification of the ECGF1 gene mutation on nuclear DNA and multiple deletions on mitochondrial DNA 3 . 
CaSE REpoRT
Patient, male, 31 years-old, son of non-consanguineous parents, and no perinatal complications, he presents a history of tonic-clonic seizures for seven years. Previously healthy, he sought assistance after the first seizure, showing no changes in neurological examination in post-crisis. The patient had complete blood count, renal and hepatic function, glucose, electrolytes, serology for HIV and toxoplasma gondii negative. 
a B C
Electrocardiogram and cardiac enzymes were normal. In that occasion, the computed tomography (CT) scan showed a bilateral calcification located in the basal ganglia ( Fig C) . Brain magnetic resonance imaging (MRI) showed extensive area of leukodistrophia and cysts in both hemispheres, the largest measuring 6.7 versus 4.8 cm, with marginal enhancement after intravenous contrast. The repeated MRI showed progression of the lesions (Fig A and B) . In the same month, the largest brain cyst was surgically removed, and the histopathological examination of the cyst showed foci of dystrophic calcifications and focal accumulations of macrophages xanthomized. There were no signs of malignancy in the sample. The patient evolved with partial control of seizures using carbamazepine 1,800 mg/day and he also performed five surgeries to remove brain cysts. Now, the patient is currently with neurological examination demonstrating cognitive syndrome characterized by a transcortical motor aphasia; 
DiSCuSSion
Reviewing the relevant literature worldwide, Labrune syndrome was considered as a possible diagnosis for the present case 2 . Despite the presence of cysts, calcification, and edema of the white substance found in our patient, suggesting neurocysticercosis, equinecocosis 3 or neoplasia, there was no serologic or histopathologic confirmation.
This syndrome is characterized by calcifications, leukodystrophy, and formation of parenchymal cysts 1 . Its onset can occur during childhood or adolescence, in an average of 12 years (7 months -59 years), but there was not one in adults in Brazil, with neurological signs such as cognitive decline, seizures and pyramidal, extrapyramidal or cerebellar signs 1, 2 . Our patient, unlike the other cases reported in literature, presented its first neurological manifestation at the age of 24. CT and MRI seen in our case were similar to the cases reported in literature, showing increased signal intensity of the white matter on MRI (T2 and FLAIR), basal ganglia calcification, and development of cysts [1] [2] [3] . Labrune reported the results of histopathology with rearrangement involving the microvessels, whereas perivascular foci of calcifications, hyaline deposits, and formation of Rosenthal fibers seem to be compatible with this change 1 . The histopathological findings of our patient were consistent with LCC. According to them, the likely primary pathologic feature is a rearrangement involving the microvessels and the formation of Rosenthal fibers 1, 4 .
In conclusion, the etiology of LCC remains unknown. In spite of relatively characteristic findings in imaging and histopathological examination, there is no uniformity in the clinical findings noted in the published articles. It can be speculated that the later age of onset, normal intelligence and slow progression, like in our patient, may indicate the shape of this rare disease in adults.
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Metamorphopsia associated with topiramate for migraine prevention
Metamorfopsia associada ao uso de topiramato para prevenção de enxaqueca A 33-year-old woman (registration 70-247/ IPUB-UFRJ) has had recurring headaches since the age of 18. She described more right-sided than left-sided throbbing, which could be severe and associated with nausea, light and noise sensitivity, and vomiting. She has had a visual aura, seeing "zig-zags", lasting for 20 to 30 minutes before the headaches. The only preventive measure she had taken in the past was divalproex sodium, with good efficacy. Because of the weight gain as a side effect, she refused to take it again. Her body mass index (BMI) was 35.3. She was started on preventive therapy with topiramate at 25 mg daily for two weeks that was to be increased weekly to 100 mg daily. After 13 days of treatment, she developed continuous visual illusions upon waking in the morning; when looking at human faces, they were distorted and swollen. On many occasions, objects in front of her appeared to be either nearer or farther away. These visual phenomena persisted for approximately 12 hours and gradually disappeared with the discontinuation of topiramate. Thereafter, she never had similar experiences. None of these events was accompanied by the loss of consciousness or headache. The patient's impressions of reality and self-recognition were preserved. The neurological and psychiatric examination was normal, and a complete examination by a neuro-ophthalmologist was normal. An EEG, with activation procedures (hyperventilation and photic stimulation), and the MRI of the brain were normal.
Metamorphopsia is a visual illusion affecting the perception of the size, shape or inclination of objects 1 . Although this condition occurs in migraine aura, topiramate has been reported to induce other visual illusions, such as palinopsia (the illusion of a persistent or recurrent visual images following the removal of the exciting stimulus) 2 and alterations in body perception ("Alice in Wonderland syndrome") in patients with migraines 3 . The mechanism by which topiramate may cause these visual illusions in migraineurs is unknown. However, because it may occur in the aura of migraines, these visual illusions are likely to be a result of the migraine.
The frontotemporal dementia (FTD) is the second most common form of dementia in patients younger than 65 years, and its behavioral variant (bvFTD) is the most prevalent form 1, 2 . During the last years, the overlapping between FTD and amyotrophic lateral sclerosis (ALS) has been frequently recognized, with symptoms of FTD preceding ALS and vice-versa. Herein, we report a case of ALS, which afterwards presented psychotic and behavioral symptoms, whose neuropathological diagnosis was compatible with bvFTD-ALS with TAR DNA-binding protein 43 (TDP-43) inclusion 3 .
CaSE REpoRT
A 58-year-old man was admitted in our Emergency Unit with a one-year history of progressive weakness of limbs, associated with dysarthria, dysphonia, difficulty to close mouth and hands atrophy. Four days before admission, he developed dyspnea and acute respiratory failure. In the hospital, it was seen generalized weakness, global hyperreflexia, fasciculations on right arm, no sensory abnormalities, and the electroneuromyography showed chronic and acute denervation signs in cranial, cervical and lumbosacral segments, confirming the diagnosis of amyotrophic lateral sclerosis. As the patient had no social and economic home support, he lived the rest of his life hospitalized, with mechanic ventilation. In the first year after admission, the patient showed anxious and depressive symptoms, associated with a permanent refusal of his condition, with great hopes of cure, even after exhaustive explanation about the diagnosis. This behavior was considered as mechanism of denial.
Progressively, the patient became hostile to nurses and physicians, blaming his disease to clinical staff, with frequent verbal aggression. He said that the family was visiting him, but there were no proof of these visits. After 2 years of hospitalization, the agressivity worsened, without improvement with antidepressants drugs. The patient affirmed that the disease could be resolved with antibiotic, but the physicians did not want to treat him. In his last months, the persecutory delusions became more intense, associated with visual hallucinations. As there were no clinical signs of delirium, a psychotic delusional disorder was diagnosed and neuroleptic medications were started. His psychiatric status progressively worsened, with auditory hallucinations and physical aggression to the clinical staff. After 2 years and 9 months of hospitalization, the patient died by asphyxia by tracheal blood clot.
On necropsy (Fig) , it was seen moderate reduction in hypoglossus nucleus and in anterior column of spinal cord motor neurons, and myelin pallor on anterior and lateral funiculi, sparing posterior funiculus (Fig C) , and the brain showed spongiosis in layer II, predominantly in temporal cortex (Fig A and B) . The immunoreactivity to protein tau was negative, but there were granular neuronal intracytoplasmatic inclusions and dystrophic neurites positive to ubiquitin and TDP-43 (subtype 3 from Mackenzie et al.) 4 .
DiSCuSSion
The discovery of TDP-43 [3] [4] [5] in brains of patients with the association FTD-ALS has improved the comprehension of its pathophysiology. This specific phenotype often shows the presence of delusions and hallucinations 1 , as seen in our case, and these symptoms should draw our attention to the possibility of TDP-43 proteinopathy on motor neuron disease. As the patient was hospitalized during almost 3 years, it was possible to register details of his behavioral degeneration.
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